ANIK vs PSA · rev $62.2M vs rev $1.23B
Anika Therapeutics Inc (ANIK) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
PSA (PSA) common stock.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
Latest reported PSA revenue for 2026-06-30 was $1.23B. Net income was $500.0M. Revenue was up 1.2% from 2026-03-31 to 2026-06-30. PSA currently screens at market cap $0.
ANIK currently screens at market cap $161.3M. PSA currently screens at market cap $0.
Not investment advice. Open the ANIK and PSA stock pages for the full models.
Not investment advice.